Quest Diagnostics
(NYSE) DGX
Quest Diagnostics Financials at a Glance
Market Cap
$23.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$11.28B
Net Income (TTM)
$1.02B
EPS (TTM)
$9.07
P/E Ratio
22.97
Dividend
$3.32
Beta (Volatility)
0.36 (Low)
Dividend
$3.32
Beta (Volatility)
0.36 (Low)
Price
$207.15
Volume
186,175.874
Open
$210.20
Price
$207.15
Volume
186,175.874
Open
$210.20
Previous Close
$208.21
Daily Range
$206.34 - $210.20
52-Week Range
$164.65 - $219.20
Estimated Earnings Date
Jul 23, 2026
Dividend
$3.32
Beta (Volatility)
0.36 (Low)
Price
$207.15
Volume
186,175.874
Open
$210.20
Previous Close
$208.21
Daily Range
$206.34 - $210.20
52-Week Range
$164.65 - $219.20
Estimated Earnings Date
Jul 23, 2026
DGX News
DGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quest Diagnostics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
57,000
CEO
James E. Davis
Website
www.questdiagnostics.comHeadquarters
Secaucus, NJ 07094, US
DGX Financials
Key Financial Metrics (TTM)
Gross Margin
33.23%
Operating Margin
14.31%
Net Income Margin
9.08%
Return on Equity
14.11%
Return on Capital
11.38%
Return on Assets
6.14%
Earnings Yield
4.35%
Dividend Yield
1.59%
Payout Ratio
34.86%
Stock Overview
Market Cap
$23.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
110.70M
Volume
186.18K
Avg. Volume
924.95K
Financials (TTM)
Gross Profit
$3.75B
Operating Income
$1.61B
EBITDA
$2.12B
Operating Cash Flow
$1.85B
Capital Expenditure
-$524.00M
Free Cash Flow
$1.33B
Cash & ST Invst.
$393.00M
Total Debt
$6.98B
Quest Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.90B
+9.2%
Gross Profit
$942.00M
+9.2%
Gross Margin
32.54%
N/A
Market Cap
$23.05BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$419.05K
N/A
Employees
55,000
N/A
Net Income
$252.00M
+14.5%
EBITDA
$434.00M
-11.1%
Quarterly Fundamentals
Total Cash
$393.00M
+109.0%
Total Debt
$6.98B
+6.2%
Accounts Receivable
$1.59B
+13.0%
Inventory
$225.00M
+19.0%
Long Term Debt
$6.30B
-1.5%
Short Term Debt
$677.00M
+289.1%
Return on Assets
6.14%
N/A
Return on Invested Capital
11.13%
N/A
Free Cash Flow
$164.00M
-16.8%
Operating Cash Flow
$278.00M
-11.5%